Hidradenitis clinical trials

Explore recruiting hidradenitis clinical trials.

Recruiting hidradenitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hidradenitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating the Long-Term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Germany, Ireland, Greece, Bulgaria, Spain, France +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, double-blind, placebo-controlled, dose-ranging Phase 2 study of brivekimig followed by a maintenance period in participants with moderate to severe hidradenitis suppurativa

Poland, Hungary, Netherlands, Germany, Czechia, Spain +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, placebo-controlled, Phase 2, dose-finding study to investigate the efficacy and safety of SAR445399 in participants with moderate to severe hidradenitis suppurativa

Hungary, Spain, France, Belgium, Sweden, Germany +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

Belgium, Germany, Austria, Poland, Spain, France +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderate to Severe Hidradenitis Suppurativa

Spain, France, Netherlands, Germany, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2, Dose Ranging, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients with Moderate to Severe Hidradenitis Suppurativa (COMPASS 2 - HS)

Spain, Germany, Czechia, Poland, Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

Hidradenitis trials by city

Hidradenitis in Toronto Hidradenitis in Vancouver Hidradenitis in Montreal Hidradenitis in Calgary Hidradenitis in Edmonton Hidradenitis in Ottawa Hidradenitis in Winnipeg Hidradenitis in Quebec City Hidradenitis in Hamilton Hidradenitis in Kitchener Hidradenitis in London Hidradenitis in Halifax Hidradenitis in New York Hidradenitis in Los Angeles Hidradenitis in Chicago Hidradenitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease